Trials / Completed
CompletedNCT00558168
Electronic Study for Anastrozole Pharmacovigilance Evaluation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,850 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Collecting information regarding adverse events from patients on treatment with anastrazole with early stage breast cancer
Conditions
Timeline
- Start date
- 2004-01-01
- Completion
- 2008-07-01
- First posted
- 2007-11-14
- Last updated
- 2008-07-28
Source: ClinicalTrials.gov record NCT00558168. Inclusion in this directory is not an endorsement.